Literature DB >> 8471401

Endogenous digoxin-like immunoreactivity during pregnancy and at birth.

J M Lupoglazoff1, E Jacqz-Aigrain, B Guyot, O Chappey, P Blot.   

Abstract

1. We have measured endogenous digoxin-like immunoreactivity (EDLI), in mothers and infants, during normal/pathological pregnancies and at birth. 2. During pregnancy, EDLI was measured in 38 maternal-fetal pairs. At the time of fetal sampling, maternal age was 29 (s.d. 6) years and gestational age was 28 (s.d. 6) weeks. EDLI was present in 13 (34%) mothers and in 27 (71%) fetuses. There was no correlation between maternal and fetal concentrations or between maternal or fetal concentrations and gestational age. 3. EDLI was measured at birth in blood samples from 45 maternal-cord pairs. Maternal age was 29 (s.d. 5) years and gestational age was 39 (s.d. 2) weeks. EDLI was present in 11 (22%) maternal and in 44 (98%) cord samples. The concentrations were significantly higher in cord than in fetal or maternal samples (P < 0.001 in both cases). 4. High cord EDLI concentrations suggest acute synthesis during delivery. Thus, the placental transfer of digoxin calculated from maternal and cord digoxin concentrations at birth may be overestimated.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8471401      PMCID: PMC1381570     

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  24 in total

1.  Fetal blood sampling during pregnancy with use of a needle guided by ultrasound: a study of 606 consecutive cases.

Authors:  F Daffos; M Capella-Pavlovsky; F Forestier
Journal:  Am J Obstet Gynecol       Date:  1985-11-15       Impact factor: 8.661

2.  Ultrasound-guided sampling of umbilical cord and placental blood to assess fetal wellbeing.

Authors:  K H Nicolaides; P W Soothill; C H Rodeck; S Campbell
Journal:  Lancet       Date:  1986-05-10       Impact factor: 79.321

3.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

4.  Digoxin-like substance in term pregnancy, newborns, and renal failure.

Authors:  L Witherspoon; S Shuler; K Alyea; J Figueroa; H Neely
Journal:  J Nucl Med       Date:  1986-09       Impact factor: 10.057

5.  Endogenous digoxin-immunoreactive substance in human pregnancies.

Authors:  S W Graves; R Valdes; B A Brown; A B Knight; H R Craig
Journal:  J Clin Endocrinol Metab       Date:  1984-04       Impact factor: 5.958

6.  Digoxin- and digitoxin-like immunoreactive substances in amniotic fluid, cord blood, and serum of neonates.

Authors:  H Ebara; S Suzuki; K Nagashima; T Koizumi; A Nishida; Y Kanbe; T Kuroume
Journal:  Pediatr Res       Date:  1986-01       Impact factor: 3.756

7.  Significance of the endogenous digoxin-like substance in infants and mothers.

Authors:  G Koren; D Farine; D Maresky; J Taylor; J Heyes; S Soldin; S MacLeod
Journal:  Clin Pharmacol Ther       Date:  1984-12       Impact factor: 6.875

8.  Dehydroepiandrosterone sulfate as a digitalis like factor in plasma of healthy human adults.

Authors:  S Vasdev; L Longerich; E Johnson; D Brent; M H Gault
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1985-09

9.  Falsely increased digoxin concentrations in samples from neonates and infants.

Authors:  J M Hicks; E M Brett
Journal:  Ther Drug Monit       Date:  1984       Impact factor: 3.681

Review 10.  Endogenous digitalis-like factors: their possible pathophysiological implications with particular regard to the perinatal period.

Authors:  P Biver; A Clerico; A Paci; S Balzan; A Boldrini; C Cipolloni
Journal:  Child Nephrol Urol       Date:  1990
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.